Table 4.

Cox regression analysis of independent prognostic factors for 30-day all-cause mortality

Variable	Univariate analysis			Multivariate analysis
	Beta	HR (95% CI)	P Value	Beta	HR (95% CI)	P Value
Age	-0.956	0.384 (0.237-0.623)	<0.001	-0.559	0.572 (0.345-0.949)	0.031
BMI	0.599	1.82 (0.737-4.498)	0.194
Gender
Male
Female	0.284	1.328 (0.834-2.115)	0.232
Cancer Type
Gastric Cancer
Esophageal Cancer	0.088	1.092 (0.694-1.719)	0.703
Other	-0.111	0.895 (0.323-2.485)	0.832
TNM Stage
II
III	0.013	1.014 (0.444-2.315)	0.975
IV	0.195	1.215 (0.579-2.551)	0.606
24 h Blood Loss
≥1000 mL
<1000 mL	-0.610	0.544 (0.34-0.87)	0.011	-0.185	0.831 (0.517-1.336)	0.446
24 h Blood Transfusion Treatment
Yes
No	-0.192	0.826 (0.532-1.281)	0.393
Time from Bleeding to Admission
≥12 h
<12 h	-0.419	0.658 (0.411-1.052)	0.081
Hemorrhagic Shock
Yes
No	-0.021	0.979 (0.560-1.713)	0.941
Received Radiation/Chemotherapy
Yes
No	0.086	1.089 (0.693-1.713)	0.711
Diabetes History
Yes
No	0.895	2.446 (1.179-5.074)	0.016	1.173	3.23 (1.507-6.926)	0.003
Hypertension History
Yes
No	0.153	1.166 (0.735-1.847)	0.515
Fluid Therapy Plan
IV
IO	-0.519	0.595 (0.374-0.947)	0.029	0.175	1.192 (0.734-1.935)	0.479
Hemostasis method
Interventional embolization
Endoscopic hemostasis	-0.463	0.630 (0.386-1.026)	0.063
First Intubation Success Rate
Success
Failure	0.138	1.148 (0.635-2.077)	0.648
Resuscitation Success Rate
Success
Failure	-0.090	0.914 (0.37-2.258)	0.845
Time of Venous Access Establishment
≥3
<3	-0.455	0.634 (0.376-1.07)	0.088
Post-Fluid BP Recovery
≥10
<10	-0.292	0.747 (0.464-1.202)	0.229
Infusion Rate
≥13
<13	-0.432	0.649 (0.344-1.225)	0.182
Urine Output
≥105
<105	0.291	1.337 (0.725-2.467)	0.352
Pre-Fluid ALB
≥49
<49	0.128	1.137 (0.602-2.146)	0.692
6 h Post-Fluid ALB
≥122
<122	0.385	1.469 (0.953-2.265)	0.082
6 h LA clearance rate
≥0.16
<0.16	-4.101	0.017 (0.009-0.031)	<0.001	-4.119	0.016 (0.009-0.031)	<0.001

Note: BMI: Body Mass Index, TNM: Tumor, Node, Metastasis, BP: Blood Pressure, ALB: Albumin, IV: Intravenous, IO: Intraosseous, IA: lactate.